A Cell Biologist's View on APOL1: What We Know and What We Still Need to Address

Area of Science:

• Genetics
• Cell Biology
• Immunology

Background:

• The APOL1 gene, unique to humans and primates, confers protection against African sleeping sickness.
• Co-evolution with parasites led to APOL1 variants that also elevate the risk of kidney diseases.
• APOL1-mediated kidney diseases (AMKDs) represent a significant health concern linked to specific APOL1 gene variants.

Purpose of the Study:

• To review the cell biology of APOL1, focusing on its protective and pathogenic roles.
• To elucidate the mechanisms underlying APOL1-associated cytotoxicity and AMKDs.
• To identify key questions and knowledge gaps regarding APOL1 function and disease association.

Main Methods:

• Literature review and synthesis of existing research on APOL1.
• Analysis of cell biologic features and functional properties of APOL1 variants.
• Discussion of the evolutionary context and disease associations of APOL1.

Main Results:

• APOL1 exhibits dual roles: protection against trypanosome infections and contribution to kidney disease pathogenesis.
• Specific APOL1 variants are strongly associated with increased risk for various kidney diseases.
• The cellular mechanisms driving APOL1-associated kidney damage are complex and not fully understood.

Conclusions:

• Understanding APOL1's cell biology is crucial for deciphering its role in kidney disease.
• Further research is needed to address unanswered questions about APOL1's cytotoxicity and its link to AMKDs.
• Targeting APOL1 pathways may offer therapeutic strategies for kidney disease prevention and treatment.